Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-03-18
2000-07-18
Woodward, Michael P.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514 21, 514832, 514833, 530380, 530385, 424529, 424530, 424533, A61K 3816, A61K 3514
Patent
active
060907797
ABSTRACT:
Therapeutic treatment of septic shock comprises administering to an animal stroma-free hemoglobin, typically at a dose ranging from the least amount effective to increase perfusion, up to a dosage of about 2500 milligrams kilograms per of body weight.
REFERENCES:
patent: 5039520 (1991-08-01), Hunter
patent: 5334706 (1994-08-01), Przybelski
patent: 5510464 (1996-04-01), Przybelski
patent: 5614490 (1997-03-01), Przybelski
Conrad, S.A. "Effect of Red Cell Transfusion on Oxygen Consumption Following Fluid Resuscitation in Septic Shock" Circ. Shock, vol. 31, No. 4, pp. 419-429, Aug., 1990 (1 page Abstract).
Parrat et al. Applied Cardiopuluronary Pthophysiology, vol. 4, pp. 143-149, 1991.
Kilboun et al, Proc. Natl. Acad. Sci. USA,vol. 87, pp. 3629-3632, May 1990.
Kilbourn et al, Biochemical and Biophysical Research Communication, vol. 172, No. 3, pp. 1132-1138, Nov. 1990.
Kosaha et al, Free Radical Biology & Medicine, vol. 7, pp. 653-658, 1989.
Bagu et al, European Journal of Pharmacology, vol. 161, pp. 61-72, 1989.
Martin et al, The Journal of Pharmacology and Eperimental Therapeutics, vol. 232, No. 3, pp. 708-716, 1985.
Cross et al, Infection and Immunity, vol. 6, No. 7, pp. 2741-2747, Jul. 1993.
Fink et al, Journal of Surgical Research, vol. 49, pp. 186-196, Jul. 1990.
Bone, Annals of Internal Medicine, vol. 115, No. 6, pp. 457-469, Sep. 1991.
Glauser et al, The Lancet, vol. 338, pp. 732-736, Sep. 1991.
Burhop Kenneth E.
Przybelski Robert J.
Baxter International Inc.
Mohamed Abdel A.
Woodward Michael P.
LandOfFree
Use of hemoglobin to treat septic shock does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of hemoglobin to treat septic shock, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of hemoglobin to treat septic shock will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2037150